Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep707 | Pituitary and Neuroendocrinology | ECE2023

Safety and efficacy of once weekly somapacitan versus once daily growth hormone among adults with growth hormone deficiency: A systematic review and meta-analysis

Co Faith Abigail , Baliclic Micah Fiel , Sese Kevin , Pagcatipunan Jr. Rodolfo S

Background: Adult growth hormone deficiency (AGHD) has been increasingly observed among patients with traumatic brain injury, stroke, and central nervous system infection, aside from the subgroup of patients with pituitary tumors. When left untreated, these patients have a significantly increased risk to develop cardiovascular morbidity and mortality and impaired psychosocial function. Existing treatment guidelines on AGHD have recommended the use of growth hormone (GH) replac...